[Clinical administration of BCG-immunotherapy in malignant melanoma (author's transl)]

In the Department of Dermatology of the University of Jena 60 patients with malignant melanoma received the immunotherapy by means of the BCG high-dosis scarification method after maximum surgical removal of the tumour. The results after 3 years of treatment demonstrate that the BCG strain Jena can cause immunostimulation. Rates of remission and survival could be well influenced. No serious side effects were observed.